Molecular mechanisms of anaphylaxis: Lessons from studies with murine models

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 3, 2005, Pages 449-457

  Finkelman, Fred D ^a,b,c   Rothenberg, Marc E ^c   Brandt, Eric B ^c   Morris, Suzanne C ^a,b   Strait, Richard T ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Blocking antibody; Fc RIIb; Fc RIII; Fc RI; IgE; IL 4 receptor chain

Indexed keywords

CYTOKINE; FC RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA ANTAGONIST; RECEPTOR BLOCKING AGENT; SEROTONIN; SEROTONIN ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANTIBODY PRODUCTION; ATOPY; CELL ACTIVATION; DESENSITIZATION; DIARRHEA; DRUG EFFICACY; DYSPNEA; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNE SYSTEM; LUNG DISEASE; MACROPHAGE; MAST CELL; MASTOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET CELL; WHEEZING;

EID: 14844318172     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.12.1125     Document Type: Review

References (68)

1. A. Worobec, and D.D. Metcalfe Anaphylactic syndrome K.F. Austen M.M. Frank J.P. Atkinson H. Cantor Samter's immunologic diseases 6th ed. 2001 Lippincott Williams & Wilkins Philadelphia 825 836
2. I. Miyajima, D. Dombrowicz, T.R. Martin, J.V. Ravetch, J.P. Kinet, and S.J. Galli Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1- dependent passive anaphylaxis J Clin Invest 99 1997 901 914
3. H.C. Oettgen, T.R. Martin, A. Wynshaw-Boris, C. Deng, J.M. Drazen, and P. Leder Active anaphylaxis in IgE-deficient mice Nature 370 1994 367 370
4. F. Bruschi, E. Pozio, N. Watanabe, M.A. Gomez-Morales, M. Ito, and Y. Huang Anaphylactic response to parasite antigens: IgE and IgG1 independently induce death in Trichinella-infected mice Int Arch Allergy Immunol 119 1999 291 296
5. R.T. Strait, S.C. Morris, M. Yang, X.W. Qu, and F.D. Finkelman Pathways of anaphylaxis in the mouse J Allergy Clin Immunol 109 2002 658 668
6. D. Dombrowicz, V. Flamand, K.K. Brigman, B.H. Koller, and J.P. Kinet Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor a chain gene Cell 75 1993 969 976
7. D. Kelefiotis, and C. Vakirtzi-Lemonias In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis Agents Actions 40 1993 150 156
8. R.T. Strait, S.C. Morris, K. Smiley, J.F. Urban Jr., and F.D. Finkelman IL-4 exacerbates anaphylaxis J Immunol 170 2003 3835 3842
9. Z. Eshhar, M. Ofarim, and T. Waks Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity J Immunol 124 1980 775 780
10. R.N. Pinckard, M. Halonen, J.D. Palmer, C. Butler, J.O. Shaw, and P.M. Henson Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion J Immunol 119 1977 2185 2193
11. S. Kimura, M. Nagata, M. Takeuchi, K. Takano, and M. Harada Anti-granulocyte antibody suppression of active and passive anaphylactic shock in WBB6F1-W/Wv mice Cell Mol Life Sci 53 1997 663 666
12. A. Ujike, Y. Ishikawa, M. Ono, T. Yuasa, T. Yoshino, and M. Fukumoto Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG J Exp Med 189 1999 1573 1579
13. T. Takeishi, T.R. Martin, I.M. Katona, F.D. Finkelman, and S.J. Galli Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses J Clin Invest 88 1991 598 608
14. E. Liu, H. Moriyama, N. Abiru, D. Miao, L. Yu, and R.M. Taylor Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23 J Clin Invest 110 2002 1021 1027
15. L. Gyenes, A.H. Sehon, S.O. Freedman, and Z. Ovary The properties of fragments of akin-sensitizing and blocking antibodies as revealed by the Prausnitz-Kuestner, passive cutaneous anaphylaxis and hemagglutination reactions Int Arch Allergy Appl Immunol 24 1964 106 118
16. R.H. Spitzer, M.A. Kaplan, and J.G. Leija Blocking activity of ragweed antibodies isolated specifically from human and rabbit sera Nature 206 1965 1015 1017
17. L.M. Lichtenstein, N.A. Holtzman, and L.S. Burnett A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody J Immunol 101 1968 317 324
18. F.D. Finkelman, C.M. Snapper, J.D. Mountz, and I.M. Katona Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response J Immunol 138 1987 2826 2830
19. S.H. Sicherer Determinants of systemic manifestations of food allergy J Allergy Clin Immunol 106 2000 251 257
20. A.W. Burks, and H.A. Sampson Anaphylaxis and food allergy Clin Rev Allergy Immunol 17 1999 339 360
21. X.M. Li, D. Serebrisky, S.Y. Lee, C.K. Huang, L. Bardina, and B.H. Schofield A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses J Allergy Clin Immunol 106 2000 150 158
22. E.B. Brandt, R.T. Strait, D. Hershko, Q. Wang, E.E. Muntel, and T.A. Scribner Mast cells are required for experimental oral allergen-induced diarrhea J Clin Invest 112 2003 1666 1677
23. A. Mishra, and M.E. Rothenberg Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism Gastroenterology 125 2003 1419 1427
24. K.B. Madden, J.F. Urban Jr., H.J. Ziltener, J.W. Schrader, F.D. Finkelman, and I.M. Katona Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis J Immunol 147 1991 1387 1391
25. F.D. Finkelman, K.B. Madden, S.C. Morris, J.M. Holmes, N. Boiani, and I.M. Katona Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes J Immunol 151 1993 1235 1244
26. A.M. Dvorak, R.I. Tepper, P.F. Weller, E.S. Morgan, P. Estrella, and R.A. Monahan-Earley Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry Blood 83 1994 3600 3612
27. F.H. Hsieh, B.K. Lam, J.F. Penrose, K.F. Austen, and J.A. Boyce T helper cell type 2 cytokines coordinately regulate immunoglobulin E- dependent cysteinyl leukotriene production by human cord blood-derived mast cells. Profound induction of leukotriene c(4) synthase expression by interleukin 4 J Exp Med 193 2001 123 134
28. S.C. Bischoff, G. Sellge, A. Lorentz, W. Sebald, R. Raab, and M.P. Manns IL-4 enhances proliferation and mediator release in mature human mast cells Proc Natl Acad Sci U S A 96 1999 8080 8085
29. M. Thivierge, J. Stankova, and M. Rola-Pleszczynski IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages J Immunol 167 2001 2855 2860
30. C.M. Nguer, O. Pellegrini, P. Galanaud, J. Benveniste, Y. Thomas, and Y. Richard Regulation of paf-acether receptor expression in human B cells J Immunol 149 1992 2742 2748
31. A. Talvani, G. Santana, L.S. Barcelos, S. Ishii, T. Shimizu, and A.J. Romanha Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice Microbes Infect 5 2003 789 796
32. A.C. Soares, V.S. Pinho, D.G. Souza, T. Shimizu, S. Ishii, and J.R. Nicoli Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria Br J Pharmacol 137 2002 621 628
33. M.V. Lonardoni, M. Russo, and S. Jancar Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection Infect Immun 68 2000 6355 6361
34. J.H. Choi, H.M. Ko, J.W. Kim, H.K. Lee, S.S. Han, and S.B. Chun Platelet-activating factor-induced early activation of NF-κB plays a crucial role for organ clearance of Candida albicans J Immunol 166 2001 5139 5144
35. H. Matsuda, N. Watanabe, Y. Kiso, S. Hirota, H. Ushio, and Y. Kannan Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice J Immunol 144 1990 259 262
36. A. Ahmad, C.H. Wang, and R.G. Bell A role for IgE in intestinal immunity. Expression of rapid expulsion of Trichinella spiralis in rats transfused with IgE and thoracic duct lymphocytes J Immunol 146 1991 3563 3570
37. M.F. Gurish, P.J. Bryce, H. Tao, A.B. Kisselgof, E.M. Thornton, and H.R. Miller IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis J Immunol 172 2004 1139 1145
38. J.F. Urban Jr., N. Noben-Trauth, L. Schopf, K.B. Madden, and F.D. Finkelman Cutting edge: IL-4 receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal nematode parasites J Immunol 167 2001 6078 6081
39. M.V. Khodoun, T. Orekhova, C. Potter, S. Morris, and F.D. Finkelman Basophils initiate IL-4 production during a memory T-dependent response J Exp Med 200 2004 857 870
40. J.V. Ravetch Fc receptors Curr Opin Immunol 9 1997 121 125
41. J.P. Kinet The high-affinity IgE receptor (FcεRI): from physiology to pathology Annu Rev Immunol 17 1999 931 972
42. J.M. Mencia-Huerta, and J. Benveniste Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes Eur J Immunol 9 1979 409 415
43. T. Ishizaka, and D.H. Conrad Binding characteristics of human IgE receptors and initial triggering events in human mast cells for histamine release Monogr Allergy 18 1983 14 24
44. P.C. Fox, L.K. Basciano, and R.P. Siraganian Mouse mast cell activation and desensitization for immune aggregate-induced histamine release J Immunol 129 1982 314 319
45. P. Inarrea, F. Alonso, and M. Sanchez-Crespo Platelet-activating factor: an effector substance of the vasopermeability changes induced by the infusion of immune aggregates in the mouse Immunopharmacology 6 1983 7 14
46. F. Bussolino, G. Camussi, M. Aglietta, P. Braquet, A. Bosia, and G. Pescarmona Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures J Immunol 139 1987 2439 2446
47. R.K. Bergman, and J.J. Munoz Effect of Bordetella pertussis extract and vasoactive amines on vascular permeability J Allergy Clin Immunol 55 1975 378 385
48. R.M. Ludatscher Ultrastructure of the immediate, histamine-mediated microvascular response in human skin with urticaria pigmentosa Microvasc Res 31 1986 345 355
49. E.L. Faquim-Mauro, R.L. Coffman, I.A. Abrahamsohn, and M.S. Macedo Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12 J Immunol 163 1999 3572 3576
50. F. Takizawa, M. Adamczewski, and J. Kinet Identification of the low affinity receptor for Immunoglobulin E on mouse mast cells and macrophages as FcγRIII J Exp Med 176 1992 469 476
51. D. Maurer, S. Fiebiger, C. Ebner, B. Reininger, G.F. Fischer, and S. Wichlas Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRIα- and FcεRIγ-chains and can use this receptor for IgE-mediated allergen presentation J Immunol 157 1996 607 616
52. T. Bieber, H. de la Salle, A. Wollenberg, J. Hakimi, R. Chizzonite, and J. Ring Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI) J Exp Med 175 1992 1285 1290
53. K. Ochiai, M. Kagami, K. Umemiya, R. Matsumura, T. Kawashima, and H. Tomioka Expression of high-affinity IgE receptor (FcεRI) on human alveolar macrophages from atopic and non-atopic patients Int Arch Allergy Immunol 111 suppl 1 1996 55 58
54. J.V. Ravetch, and S. Bolland IgG Fc receptors Annu Rev Immunol 19 2001 275 290
55. J. Ring, and U. Darsow Idiopathic anaphylaxis Curr Allergy Asthma Rep 2 2002 40 45
56. T. Dybendal, A.B. Guttormsen, S. Elsayed, B. Askeland, T. Harboe, and E. Florvaag Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia Acta Anaesthesiol Scand 47 2003 1211 1218
57. D.B. Golden Patterns of anaphylaxis: acute and late phase features of allergic reactions Novartis Found Symp 257 2004 101 110 discussion 10-5,57-60,276-85
58. A.J. Bircher, C.H. Czendlik, S.L. Messmer, P. Muller, and H. Howald Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction J Allergy Clin Immunol 98 1996 994 996
59. D. Laroche, F. Namour, C. Lefrancois, I. Aimone-Gastin, A. Romano, and J. Sainte-Laudy Anaphylactoid and anaphylactic reactions to iodinated contrast material Allergy 54 suppl 58 1999 13 16
60. M. Daeron, J. Couderc, M. Ventura, P. Liacopoulos, and G.A. Voisin Anaphylactic properties of mouse monoclonal IgG2a antibodies Cell Immunol 70 1982 27 40
61. S.E. McKenzie, S.M. Taylor, P. Malladi, H. Yuhan, D.L. Cassel, and P. Chien The role of the human Fc receptor FcγRIIA in the immune clearance of platelets: a transgenic mouse model J Immunol 162 1999 4311 4318
62. D.Y. Leung, H.A. Sampson, J.W. Yunginger, A.W. Burks Jr., L.C. Schneider, and C.H. Wortel Effect of anti-IgE therapy in patients with peanut allergy N Engl J Med 348 2003 986 993
63. D. Duplay Physician's desk reference 58th ed. 2004 Thomson PDT Montvale, NJ
64. D. Zhu, C.L. Kepley, M. Zhang, K. Zhang, and A. Saxon A novel human immunoglobulin Fcγ-Fcε bifunctional fusion protein inhibits FcεRI-mediated degranulation Nat Med 8 2002 518 521
65. K. Zhang, C.L. Kepley, T. Terada, D. Zhu, H. Perez, and A. Saxon Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein J Allergy Clin Immunol 114 2004 321 327
66. D. Dombrowicz, A.T. Brini, V. Flamand, E. Hicks, J.N. Snouwaert, and J.P. Kinet Anaphylaxis mediated through a humanized high affinity IgE receptor J Immunol 157 1996 1645 1651
67. D. Serebrisky, A.A. Teper, C.K. Huang, S.Y. Lee, T.F. Zhang, and B.H. Schofield CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma J Immunol 165 2000 5906 5912
68. F.D. Finkelman, I.M. Katona, J.F. Urban Jr., J. Holmes, J. Ohara, and A.S. Tung IL-4 is required to generate and sustain in vivo IgE responses J Immunol 141 1988 2335 2341